| Literature DB >> 22397492 |
Sandro Mazzariol1, Federica Marcer, Walter Mignone, Laura Serracca, Mariella Goria, Letizia Marsili, Giovanni Di Guardo, Cristina Casalone.
Abstract
BACKGROUND: Although Morbillivirus and Toxoplasma gondii have emerged as important pathogens for several cetaceans populations over the last 20 years, they have never been identified together in a Mysticete. In particular, morbilliviral infection has been never described in the Mediterranean fin whale population. CASEEntities:
Mesh:
Substances:
Year: 2012 PMID: 22397492 PMCID: PMC3319419 DOI: 10.1186/1746-6148-8-20
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Figure 1Steps of the necropsy carried out on the stranded whale. Biometrical measurements were taken before starting post-mortem analyses (A). A severe cutaneous parasitic infestation by Pennella spp. (B) was evident during external examination and a poor body condition was assessed due to a reduction of the blubber layer (C).
Figure 2Molecular analyses yielded a positive result for . RT-PCR targeting Morbillivirus nucleoprotein (N) gene gave positive results from the whale's spleen (lane 2), liver (lane 3), and lung (lane 4), while the heart was negative (lane 1); positive and negative controls (C + and C-, respectively) are also shown in figure A along with the DNA ladder marker. Each result was confirmed by means of both sequence and RFLP: the latter is shown in figure B with the positive reaction for spleen (lane 1), liver (lane 2), and lung (lane 3). Immunohistochemistry (IHC) using a commercially available mouse monoclonal antibody (MoAb) solution (1:500) against canine distemper virus (CDV) nucleoprotein antigen (VMRD Inc), which recognizes the same epitope from different members of the Morbillivirus genus (including DMV) was negative, possibly due to bad tissue preservation.
Figure 3Molecular and immunohistochemical studies confirmed the presence of . PCR techniques amplifying a conserved region of coccidian parasites yielded positive results for T. gondii in the heart (lane 1), skeletal muscle (lane 2), mesenteric lymph node (lane 3), and kidney (lane 4); positive and negative controls (C + and C-, respectively) are also shown in figure A along with the DNA ladder marker. IHC by means of a commercially available goat polyclonal anti-T. gondii antiserum solution (1:1000; VMRD Inc, Pullman, WA) showed rare T. gondii cysts embedded into both the myocardial (B; 400×, bar = 20 μm) and the renal tissue.